| Application no. and date | 10173234.5 (espacenet) (Federated) (European Patent Register), 20030219 | | Patent/reg. no. and date | DK/EP 2258394, 20130515 | | Publication date | 20101208 | | Priority no. and date | EP 02003811, 20020220, DE 10207160, 20020220 | | EP pub. no. and date |
EP 2258394 20101208 | | Effective date | | | Applicant/owner | AstraZeneca AB,
SE 151 85 Södertälje, SE | | Applicant ref. no. | p52233DK01 | | Inventor | Dietrich, Rango,
Im Tiergarten 16
78465, Konstanz, DE,
Ney, Hartmut,
Peter-Thumb-Str. 46
78464, Konstanz, DE,
Eistetter, Klaus,
Säntisblick 7
78465, Konstanz, DE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/166 (2006.01) , A61K 31/44 (2006.01) , A61K 45/06 (2006.01) , A61K 9/20 (2006.01) , A61P 11/06 (2006.01) | | Title | Oral doseringsform omfattende en PDE 4-inhibitor som en aktiv bestanddel og polyvinylpyrrolidon som excipiens | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
